GGI
TEVA icon

GordonMD Global Investments’s Teva Pharmaceuticals TEVA Stock Holding History

GordonMD Global Investments’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.4M Buy
2,402,495
+1,145,000
+91% +$38.1M 7.92% 4
2026
Q1 		$5.62M Buy
1,257,495
+487,945
+63% +$15.7M 3.91% 9
2025
Q4 		$24M Buy
+769,550
New +$19M 17.22% 2

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

GordonMD Global Investments's TEVA Position: Q2 2026 in Review

GordonMD Global Investments increased its Teva Pharmaceuticals (TEVA) stake by 91% in Q2 2026, buying an estimated $38.1M and bringing the position to 2,402,495 shares worth $16.4M. The position accounts for 7.92% of the portfolio, ranked #4.

GordonMD Global Investments first reported a position in TEVA in Q4 2025 and has held it in 3 quarters since. The position peaked at $24M in Q4 2025. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • GordonMD Global Investments held 2,402,495 shares of Teva Pharmaceuticals worth $16.4M as of Q2 2026.
  • GordonMD Global Investments bought 1,145,000 Teva Pharmaceuticals shares in Q2 2026, an estimated $38.1M.
  • Teva Pharmaceuticals made up 7.92% of GordonMD Global Investments's portfolio in Q2 2026, its #4 holding.
  • GordonMD Global Investments first reported a position in Teva Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • GordonMD Global Investments's Teva Pharmaceuticals position peaked at $24M in Q4 2025.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on GordonMD Global Investments's 13F filing for Q2 2026, filed 14 Aug 2026.